Notice of Intent to Sole Source to CN-Bio Innovations Inc.

Closed Pre-Solicitation Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
FDA-SS-RFQ-2020-1233532
Agency
Responses due
Set-aside
8(a) Sole Source

Opportunity facts

Place of performance
Laurel MD 20708 USA

Notice details come from SAM.gov. Updated .

Notice text

The Food and Drug Administration (FDA) has a requirement under Request for Quotes: FDA-SS-RFQ-2020-1233532 to procure a PhysioMimix CN Bio Organ Chip Equipment System, plus four (4) option years (12 Months) of Preventative Maintenance Agreement (PMA) as a sole source acquisition.

Files

File Type Posted
Notice of Intent to Sole Source.pdf PDF

Notice history

Notice Type Posted
ELISA Kit Procurement for On-Going Work on Allergens Detection Latest pre-solicitation Pre-Solicitation
This notice Pre-Solicitation
Notice of Intent - Sole Source to Illumina Original Limited / Sole Source Justification

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors